Trends in Population-Based Incidence and Prevalence of Juvenile Idiopathic Arthritis in Manitoba, Canada.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
03 2019
Historique:
received: 28 12 2017
accepted: 22 05 2018
pubmed: 26 5 2018
medline: 28 11 2019
entrez: 26 5 2018
Statut: ppublish

Résumé

To estimate the incidence and prevalence of juvenile idiopathic arthritis (JIA) in children ages <16 years in the province of Manitoba, Canada, and to determine changes in estimates between 2000 and 2012. JIA cases were ascertained from the administrative health data of Manitoba, using a validated case-finding algorithm. Annual incidence and prevalence rates were estimated using a generalized linear model with generalized estimating equations (GEEs), adjusting for sociodemographic characteristics. Changes in estimates were tested using piecewise regression models. A total of 455 cases of JIA prevalence met the inclusion criteria. Sex- and age-adjusted incidence estimates were 14.01 (95% confidence interval [95% CI] 13.52, 14.53) in 2000/2001 and 9.18 (95% CI 8.56, 9.85) in 2010/2011. Prevalence estimates were 65.33 (95% CI 63.87, 66.83) in 2000/2001 and 59.61 (95% CI 58.17, 61.08) in 2010/2011. A linear piecewise model provided the best fit to the data. There was a significant decrease in prevalence over the study period (-0.18 [95% CI -0.35, -0.02]; P = 0.0292) but no statistically significant change in incidence (-0.46 [95% CI -0.94, 0.01]; P = 0.0571). Sex-stratified models revealed a decrease for males in both prevalence (estimate -0.54 [95% CI -0.84, -10.25]; P = 0.0003) and incidence (estimate -1.02 [95% CI -2.02, -0.04]; P = 0.0439); there were no changes for females. Few population-based longitudinal epidemiologic studies of JIA have been conducted. Our findings suggested a decrease in overall JIA prevalence, and in incidence and prevalence in men. Further research to validate these findings in other cohorts and to explore factors that contribute to this change will benefit future health care planning for JIA.

Identifiants

pubmed: 29799673
doi: 10.1002/acr.23606
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-418

Subventions

Organisme : Saskatchewan Health Research Foundation
ID : New Investigator Establishment Grant
Pays : International

Informations de copyright

© 2018, American College of Rheumatology.

Auteurs

Natalie J Shiff (NJ)

University of Florida, Gainesville and University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Kiem Oen (K)

University of Manitoba, Winnipeg, Manitoba, Canada.

Kristine Kroeker (K)

University of Manitoba, Winnipeg, Manitoba, Canada.

Lisa M Lix (LM)

University of Manitoba, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH